Cryo-Cell International's EBIT per Share for the
three
months ended in Feb. 2024 was $0.13.
Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $-1.54.
During the past 12 months, the average EBIT per Share Growth Rate of Cryo-Cell International was -38.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -21.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -10.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Cryo-Cell International's EBIT per Share or its related term are showing as below:
CCEL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -62.8 Med: 9.6 Max: 58.7
Current: -21.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cryo-Cell International was 58.70% per year. The lowest was -62.80% per year. And the median was 9.60% per year.
CCEL's 3-Year EBIT Growth Rate is ranked worse than 84.62% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 8
vs CCEL: -21.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.54
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Cryo-Cell International EBIT per Share Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 